- Origin: Missouri
- Grant awarded in: 2013
Involved Industries:
Contact Information
Support Organizations:
-
Amos Danielli
Founder
-
Jenn Wilsey
Scientist
-
Jasenka Verbarg
Senior Scientist
What is MagBiosense?
MagBiosense is a biotechnology platform developed to commercialize a novel cardiac biomarker diagnostic technology that brings lab-quality, high-sensitivity detection to the point-of-care. The device will change how heart attacks are diagnosed in the Emergency Department by providing high-sensitivity detection of cardiac troponin I.
Company Leadership
Amos Danielli
Amos Danielli is the Founder of MagBiosense, a 2013 Arch Grants recipient.
Amos earned his degree in Electrical Engineering from Tel Aviv University in 1997, and holds both a Masters and PhD in Physical-Electronics from Tel Aviv University. Amos worked with Washington University in St. Louis and Helioris Solar Systems before joining MagBiosense.
Jenn Wilsey
Jasenka Verbarg
Jasenka Verbarg is the Senior Scientist at MagBiosense, a 2013 Arch Grants recipient.
Jasenka earned her degree in Biomedical Engineering from Saint Louis University in 2006, and holds a PhD in Biological Engineering from University of Missouri-Columbia. Before joining MagBiosense, Jasenka worked with the Naval Research Laboratory and the University of Missouri.
